HIV/AIDS Clinical Trials in New York

Showing 141-160 of 342 trials

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

NCT01543152

The purpose of the study is to evaluate the safety, tolerability and effect on HIV viral load, of escalating doses of cyclophosphamide administered 1 day prior to SB-728-T infusion.

HIV

Sangamo Therapeutics26 participantsStarted Dec 2011

Los Angeles, California, United States • San Francisco, California, United States • Norwalk, Connecticut, United States +8 more locations

COMPLETEDNA< 1 mile

Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care

NCT03939455

Because adolescents and young adults face markedly increased HIV risk yet frequently do not test, we propose to complete the Mobile Augmented Screening (MAS) tool designed to increase HIV testing, and to facilitate linkage to care and ongoing prevention education. This tool will help clinicians address undiagnosed youth HIV, and enable young patients to receive much needed treatment and avoid unknowingly transmitting infection. Our product is designed to help existing program staff reach an increased number of clients; and to improve public health by encouraging reluctant young patients to accept important HIV testing and care they may otherwise decline.

HIV Testing

New York University295 participantsStarted Jul 2019

New York, New York, United States

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care

HIV/AIDS Trials in Other Cities

Eliminating Hepatitis C Virus

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations

Get Ready And Empowered About Treatment

Improve Functional Health Status in Minority Women With HIV

Triggered Escalating Real-time Adherence (TERA) Intervention

Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users

Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART

Tesamorelin Effects on Liver Fat and Histology in HIV

Targeting Effective Analgesia in Clinics for HIV - Intervention

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Other Conditions in New York